Compared with placebo, SGLT2 inhibitors reduced heart failure hospitalizations among patients with history of myocardial infarction. Sodium-glucose co-transporter 2 (SGLT2) inhibitors may ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 inched down 0.73% to 1,117.65 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE ...

SGLT2 inhibitors are widely recommended for use in most patients. Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization's ...

The first cohort included 36,082 GLP-1 receptor agonist users and 234,028 DPP-4 inhibitor users, and the second cohort included 32,336 GLP-1 receptor agonist users and 96,212 SGLT-2 inhibitor users.

SGLT2 inhibitors are a new family of agents, which occlude the path of SGLT2 glucose reabsorption and cause glucosuria. Efficacy of SGLT2 inhibitors includes reduction of HbA1c, fasting and ...

In an observational study, SGLT2i and GLP1-RA appeared to offer the most kidney protection in real-world patients with type 2 diabetes. Patients with type 2 diabetes may have the lowest risk of ...

If you've been following along on the Dr. Stone season 4 release schedule, you'll know that a break for Science Future is forthcoming. With that in mind, it's worth running the rule over what's ...

New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...

VENT-02 is a novel, oral, brain-penetrant inhibitor of NLRP3, a key driver of inflammation and component of the innate immune system that plays a critical role in a wide range of inflammatory ...

What do you wonder? By The Learning Network A new collection of graphs, maps and charts organized by topic and type from our “What’s Going On in This Graph?” feature. By The Learning ...

The study, published in the Journal of the American Medical Association (JAMA), found that SGLT2 inhibitors and GLP-1 receptor agonists ... Contact no. 011-43720751 Dr. Kamal Kant Kohli Dr Kamal Kant ...